Drug-drug Interaction Study Between EDP-305, Intraconazole and Rifampin in Healthy Volunteers

Summary

This is a non-randomized, 2-part, open-label, drug-drug interaction (DDI) study to evaluate the effect of concomitant administration of itraconazole or rifampin on the pharmacokinetics and safety of EDP-305 in healthy human volunteers.

Timeline

Start

2017-07-11

Primary completion

2017-08-10

Completion

2017-09-07

Drugs

Indications